Dr. Henry Daniell

Biography

Henry Daniell is a prominent researcher focusing on the pioneering approach to oral delivery of biopharmaceuticals, which addresses critical healthcare inequities. He has developed methods to deliver affordable biopharmaceuticals while circumventing the need for refrigeration and expensive injections. His research encompasses a range of applications, including drugs for dental caries, diabetes, hemophilia, and vaccines for cholera, tuberculosis, and polio. Daniell collaborates with students to explore oral delivery systems that enhance therapeutic proteins' efficacy and aims to facilitate vaccine delivery that promotes systemic immunity. His lab's work is underpinned by substantial funding from NIH grants and notable foundations, leading to over 200 publications and more than 150 global patents. He is a fellow of the American Association for the Advancement of Science and has received numerous accolades for his contributions to science, including several prestigious awards from the American Diabetes Association and American Heart Association. His innovative concepts in biotechnology and their impact have been recognized widely, featuring in high-impact journals and global media. Daniell's academic effectiveness is complemented by a history of teaching excellence and significant editorial contributions to scientific journals.

Research Interests

Experience